493 results
Transcatheter tricuspid valve replacement in carcinoid heart disease: A multimodality‑guided, patient-centered approach
03 Apr 2026
A 74-year-old woman with carcinoid syndrome develops progressive NYHA III dyspnoea and marked fatigue, despite well-controlled systemic symptoms. Echocardiography reveals torrential tricuspid regurgitation with carcinoid valve involvement, while surgical risk is deemed high due to age, frailty, and systemic disease. How would your Heart Team approach...

Author
TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation
31 Mar 2026
Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Author
Two-year outcomes after transcatheter tricuspid repair without cross-over in the randomised TRI-FR trial
28 Mar 2026
Alex Sticchi interviews Erwan Donal on the 2-year outcomes of the TRI-FR randomised trial evaluating transcatheter tricuspid edge-to-edge repair (T-TEER) versus medical therapy alone, as presented at ACC.26 in New Orleans.

Author

Author
Atrial mitral and tricuspid regurgitation
23 Feb 2026
Register for free to this webinar on Thursday 9 April at 5:00pm with M. Adamo, M. Sitges and P. Lurz, D. Muraru and T. De Potter and learn about epidemiology and clinical presentation of combined MR and TR in patients with AF,...
How should I treat a torrential tricuspid valve regurgitation in a young patient who remains symptomatic despite optimal medical therapy?
19 Feb 2026
A frail patient presents with worsening NYHA class III dyspnoea and peripheral oedema despite optimal medical therapy. Previously managed conservatively, severe tricuspid regurgitation has progressed to a torrential grade, with right-sided chamber dilatation and complex valve anatomy.
How would you treat this patient?

Author

Author
PCRonline @ ACC 2026 Scientific Sessions
12 Mar 2026
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2026 Scientific Sessions #ACC26
Miscellaneous complications: my worst nightmare
15 Feb 2026 – From PCR Tokyo Valves 2026
Explore the prevention and management of complications arising from transcatheter interventions in structural heart disease through challenging case analyses. This session presents real-world scenarios addressing complications encountered during TAVI, mitral, and tricuspid procedures, highlighting strategies to anticipate and manage these critical events effectively.
Procedural imaging for tricuspid valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
Dedicated to procedural imaging for tricuspid valve interventions, this session elucidates anatomical and pathophysiological features critical for successful transcatheter procedures. It emphasizes technical aspects of TEE and ICE imaging, including 3D multiplanar reconstruction, and offers case-based learning to refine imaging skills and optimize procedural outcomes.